Page 74 - MEMORIA_SEHH-FEHH_2023
P. 74
MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
Sánchez-Guijo F, Molero A, Montoro J, Serrano G, Díaz-Mazkiaran A, Lasaga M, Gómez-
Cabrero D, Díez-Campelo M, Valcárcel D, Hernaez M, Romero JP, Prósper F.
• Consensus proposal for revised International Working Group 2023 response criteria
for higher-risk myelodysplastic syndromes.
Blood. 2023;141(17):2047-61. doi: 10.1182/blood.2022018604.
Zeidan AM, Platzbecker U, Bewersdorf JP, Stahl M, Adès L, Borate U, Bowen D, Buckstein
R, Brunner A, Carraway HE, Daver N, Díez-Campelo M, de Witte T, DeZern AE, Efficace
F, Garcia-Manero G, Garcia JS, Germing U, Giagounidis A, Griffiths EA, Hasserjian RP,
Hellström-Lindberg E, Iastrebner M, Komrokji R, Kulasekararaj AG, Malcovati L, Miyazaki
Y, Odenike O, Santini V, Sanz G, Scheinberg P, Stauder R, van de Loosdrecht AA, Wei AH,
Sekeres MA, Fenaux P.
• Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An
Analysis of the Spanish Group of Myelodysplastic Syndromes.
Hemasphere. 2023;7(10):e961. doi: 10.1097/HS9.0000000000000961.
Mosquera Orgueira A, Pérez Encinas MM, Díaz Varela NA, Mora E, Díaz-Beyá M, Montoro
MJ, Pomares H, Ramos F, Tormo M, Jerez A, Nomdedéu JF, De Miguel Sánchez C, Leonor
A, Cárcel P, Cedena Romero MT, Xicoy B, Rivero E, Del Orbe Barreto RA, Díez-Campelo
M, Benlloch LE, Crucitti D, Valcárcel D.
• A sex-informed approach to improve the personalized decision making process in
myelodysplastic syndromes: a multicentre, observational cohort study.
Lancet Haematol. 2023;10(2):e117-e128. doi: 10.1016/S2352-3026(22)00323-4.
GenoMed4All consortium: Maggioni, G Bersanelli M, Travaglino E, Piérola AA, Kaspr-
zak A. Arnan Sangerman M, Sauta E, Sala C, Matteuzzi T, Meggendorfer M, Gnocchi
M, Zhao, LP Tentori CA, Nachtkamp K, Dall’Olio D, Mosca E, Ubezio M, Campagna
A, Russo A, Rivoli G, Bernardi, M Borin L, Voso MT, Riva M, Oliva E, Zampin M, Riva
E, Saba E, D’Amico S, Lanino L, Tinterri, B Re F, Bicchieri, M Giordano L, Angelotti, G
Morandini P, Kubasch AS, Passamonti F, Rambaldi A, Savevski, V Santoro, A van de
Loosdrecht AA, Brogi A, Santini V, Kordasti S, Sanz G, Sole F, Gattermann N, Kern W,
Platzbecker U, Ades L, Fenaux P, Haferlach T, Castellani G, Germing U, Diez-Campelo
M, Della Porta MG.
• Incidence and prognostic impact of U2AF1 mutations and other gene alterations in
myelodysplastic neoplasms with isolated 20q deletion.
Cancer Med. 2023;12(16):16788-92. doi: 10.1002/cam4.6300.
Castillo MI, Ribate VE, Muñoz CM, Santillana SG, Taboada SE, Casterá ME, Abinzano CMJ,
Barranco IA, Nieto CR, Pampliega VM, Blanco ML, de Andrés ÁS, de Oteyza PJ, Del Cas-
74
